Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies.
about
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert groupNeuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated EntitiesProgressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.Natalizumab in Multiple Sclerosis: Long-Term Management.Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathyDisease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.Strategy in Regulatory Decision-Making for Management of Progressive Multifocal Leukoencephalopathy.Treatment-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Comprehensive Review of Current Evidence and Future Needs.Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective.Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study.Drug-induced progressive multifocal leukoencephalopathy: Lessons learned from contrasting natalizumab and rituximab.MRI pattern in asymptomatic natalizumab-associated PML.Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants.Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients.
P2860
Q26780412-6EDCC635-10E5-41D8-986C-99F5E538A41DQ26781389-3D370867-641B-47EF-87DD-086DE488ACF1Q30235523-FE74B609-2296-4D69-A5FA-967827831786Q30276550-073D9EE7-5AAD-47A1-A2A2-9326DF6C0888Q30613846-F178B56B-A02B-4619-A4A0-726B6A8AC69BQ33754882-7A4D8386-6739-41C9-A958-A6AFD8D3BB1DQ34324861-24E29603-B945-43A0-9F53-012860BD22FEQ37206687-98B1A8EF-7C3A-4100-BDD7-545E7819F2DCQ38562161-A5DB7461-7CD4-4444-A676-CBB366936490Q38815391-88337B10-C6D0-4853-9ABE-28C84453B961Q39046213-9D927258-A1CE-4B8E-A6C4-FFB06CD12E4DQ39391443-C7E51F4A-826B-4BFB-BBCA-0E4003219138Q39650695-CEFF19DE-15F8-4A13-91F0-7A200E6B2BB6Q41393684-0095BB6F-71CB-4DAA-8308-994AE5ACACBEQ41745436-E6DFA325-695A-44B7-B891-0D23D089DE5DQ42226607-4E2A06FF-22E8-41EF-BED9-1A7195AAA2F4Q45737722-E99FDA1E-10C3-4FCA-AB5F-EECB998340D2Q48612438-58EAAB83-051D-44B5-994D-2F13F07B23E2
P2860
Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Case definition for progressiv ...... nt with monoclonal antibodies.
@en
Case definition for progressiv ...... nt with monoclonal antibodies.
@nl
type
label
Case definition for progressiv ...... nt with monoclonal antibodies.
@en
Case definition for progressiv ...... nt with monoclonal antibodies.
@nl
prefLabel
Case definition for progressiv ...... nt with monoclonal antibodies.
@en
Case definition for progressiv ...... nt with monoclonal antibodies.
@nl
P2093
P356
P1476
Case definition for progressiv ...... nt with monoclonal antibodies.
@en
P2093
Brigitte Keller-Stanislawski
Dirk Mentzer
Hartmut Hengel
Jürgen Prestel
Ortwin Adams
Wolf-Dieter Ludwig
P304
P356
10.1136/JNNP-2012-302478
P407
P577
2012-07-17T00:00:00Z